<?xml version="1.0" encoding="UTF-8"?>
<AntisenseML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="antisenseML.xsd" version="1.00">
	<Target TargetType="miRNA" miRBaseAccessionNumber="MI0000077">
		<Description>Homo sapiens miR-21 stemp-loop</Description>
		<Sequence StartIndex="1" Length="72">UGUCGGGUAGCUUAUCAGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGAUGGGCUGUCUGACA</Sequence>
		<Information>&quot;Mature sequence Accession:MIMAT0000076;ID:hsa-miR-21 Sequence(8-29) 5'-uagcuuaucagacugauguuga-3'&quot;</Information>
	</Target>
	<AntiAgent>
		<AntiSeq AntiType="AOs" AntiID="AOs000001" SeqType="DNA" RefIDs="ref000001">
			<Seq length="22" strand="-" Position="Fs|8-29" Source="synthenticOligo" shRNAseq="">TCAACATCAGTCTGATAAGCTA</Seq>
			<Modification ModPosition="1-22">2'-MOE PO</Modification>
		</AntiSeq>
		<AntiSeq AntiType="AOs" AntiID="AOs000002" SeqType="DNA" RefIDs="ref000001">
			<Seq length="22" strand="-" Position="Fs|8-29" Source="synthenticOligo" shRNAseq="">TCAACATCAGTCTGATAAGCTA</Seq>
			<Modification ModPosition="1-22">2'-MOE PS</Modification>
		</AntiSeq>
		<AntiSeq AntiType="AOs" AntiID="AOs000003" SeqType="DNA" RefIDs="ref000001">
			<Seq length="22" strand="-" Position="Fs|8-29" Source="synthenticOligo" shRNAseq="">TCAACATCAGTCTGATAAGCTA</Seq>
			<Modification ModPosition="1-12">2'-MOE PS</Modification>
		</AntiSeq>
		<AntiSeq AntiType="AOs" AntiID="AOs000004" SeqType="DNA" RefIDs="ref000001">
			<Seq length="22" strand="-" Position="Fs|8-29" Source="synthenticOligo" shRNAseq="">TCAACATCAGTCTGATAAGCTA</Seq>
			<Modification ModPosition="11-22">2'-MOE PS</Modification>
		</AntiSeq>
		<AntiSeq AntiType="AOs" AntiID="AOs000005" SeqType="DNA" RefIDs="ref000001">
			<Seq length="22" strand="-" Position="Fs|8-29" Source="synthenticOligo" shRNAseq="">TCAACATCAGTCTGATAAGCTA</Seq>
			<Modification ModPosition="6-17">2'-MOE PS</Modification>
		</AntiSeq>
		<AntiSeq AntiType="AOs" AntiID="AOs000006" SeqType="DNA" RefIDs="ref000001">
			<Seq length="22" strand="-" Position="Fs|8-29" Source="synthenticOligo" shRNAseq="">TCAACATCAGTCTGATAAGCTA</Seq>
			<Modification ModPosition="1-22">2'-OMe PS</Modification>
		</AntiSeq>
		<AntiSeq AntiType="AOs" AntiID="AOs000007" SeqType="DNA" RefIDs="ref000001">
			<Seq length="22" strand="-" Position="Fs|8-29" Source="synthenticOligo" shRNAseq="">TCAACATCAGTCTGATAAGCTA</Seq>
			<Modification ModPosition="1-22">2'-OMe PO</Modification>
		</AntiSeq>
		<AntiSeq AntiType="AOs" AntiID="AOs000008" SeqType="DNA" RefIDs="ref000001">
			<Seq length="22" strand="-" Position="Fs|8-29" Source="synthenticOligo" shRNAseq="">TCAACATCAGTCTGATAAGCTA</Seq>
			<Modification ModPosition="1-5,16-22">2'-MOE PS</Modification>
		</AntiSeq>
		<AntiSeq AntiType="AOs" AntiID="AOs000009" SeqType="DNA" RefIDs="ref000001">
			<Seq length="22" strand="-" Position="Fs|8-29" Source="synthenticOligo" shRNAseq="">TCAACATCAGTCTGATAAGCTA</Seq>
			<Modification ModPosition="1,3,5,7,9,11,13,15,17,19,21,22">2'-MOE PS</Modification>
		</AntiSeq>
		<AntiSeq AntiType="AOs" AntiID="AOs000010" SeqType="DNA" RefIDs="ref000002">
			<Seq length="21" strand="-" Position="Fs|8-29" Source="synthenticOligo" shRNAseq="">ucaacacagucugauaagcua</Seq>
			<Modification ModPosition="1-21">2'-OMe</Modification>
		</AntiSeq>
		<AntiAssay AssayType="InVitro" SeriesID="sid200634" RefIDs="ref000001" Transfection_Method="Lipofectin">
			<Efficacy AntiID="AOs000001" RefID="ref000001" CtrlIDs="ctr000001" CellLine="Hela" AssayLevel="miRNA" AssayMethod="luciferase reporter assay" Conc="33 nM">++++</Efficacy>
			<Efficacy AntiID="AOs000002" RefID="ref000001" CtrlIDs="ctr000001" CellLine="Hela" AssayLevel="miRNA" AssayMethod="luciferase reporter assay" Conc="33 nM">+++</Efficacy>
			<Efficacy AntiID="AOs000003" RefID="ref000001" CtrlIDs="ctr000001" CellLine="Hela" AssayLevel="miRNA" AssayMethod="luciferase reporter assay" Conc="33 nM">+++</Efficacy>
			<Efficacy AntiID="AOs000004" RefID="ref000001" CtrlIDs="ctr000001" CellLine="Hela" AssayLevel="miRNA" AssayMethod="luciferase reporter assay" Conc="33 nM">+</Efficacy>
			<Efficacy AntiID="AOs000005" RefID="ref000001" CtrlIDs="ctr000001" CellLine="Hela" AssayLevel="miRNA" AssayMethod="luciferase reporter assay" Conc="33 nM">+</Efficacy>
			<Efficacy AntiID="AOs000006" RefID="ref000001" CtrlIDs="ctr000001" CellLine="Hela" AssayLevel="miRNA" AssayMethod="luciferase reporter assay" Conc="33 nM">+</Efficacy>
			<Efficacy AntiID="AOs000007" RefID="ref000001" CtrlIDs="ctr000001" CellLine="Hela" AssayLevel="miRNA" AssayMethod="luciferase reporter assay" Conc="33 nM">+</Efficacy>
			<Efficacy AntiID="AOs000008" RefID="ref000001" CtrlIDs="ctr000001" CellLine="Hela" AssayLevel="miRNA" AssayMethod="luciferase reporter assay" Conc="33 nM">-</Efficacy>
			<Efficacy AntiID="AOs000009" RefID="ref000001" CtrlIDs="ctr000001" CellLine="Hela" AssayLevel="miRNA" AssayMethod="luciferase reporter assay" Conc="33 nM">-</Efficacy>
			<Control CtrlID="ctr000001" CtrlType="NC" CtrlSeq="Unrated sequence" AssayLevel="miRNA" AssayMethod="luciferase reporter assay" CtrlConc="33 nM"/>
			<Figure>
				<Title/>
				<Annotation/>
			</Figure>
			<Comments>dididd</Comments>
		</AntiAssay>
		<AntiAssay AssayType="InVitro" SeriesID="sid200533" RefIDs="ref000002" Transfection_Method="lipofectamine 2000">
			<Efficacy AntiID="AOs000010" RefID="ref000002" CtrlIDs="ctr000002" CellLine="Hela" AssayLevel="miRNA" AssayMethod="miRNA array" Conc="10-30 pmol ">+++</Efficacy>
			<Efficacy AntiID="AOs000010" RefID="ref000002" CtrlIDs="ctr000002" CellLine="A549" AssayLevel="miRNA" AssayMethod="miRNA array" Conc="10-30 pmol">++++</Efficacy>
			<Control CtrlID="ctr000002" CtrlType="NC" CtrlSeq="guggauauuguugccauca" AssayLevel="miRNA" AssayMethod="miRNA array" CtrlConc="10-30 pmol "/>
			<Figure>
				<Title/>
				<Annotation/>
			</Figure>
			<Comments/>
		</AntiAssay>
	</AntiAgent>
	<Reference RefID="ref000001">
		<Author>Scott Davis, Bridget Lollo, Susan Freier and Christine Esau</Author>
		<Title>&quot;Improved targeting of miRNA with antisense oligonucleotides&quot;</Title>
		<Journal>Nucleic Acids Research</Journal>
		<Date>2006</Date>
		<Volumn>34</Volumn>
		<Issue>8</Issue>
		<Pages>2294-2304</Pages>
	</Reference>
	<Reference RefID="ref000002">
		<Author>Angie M. Cheng, Mike W. Byrom, Jeffrey Shelton and Lance P. Ford</Author>
		<Title>Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis</Title>
		<Journal>Nucleic Acids Research</Journal>
		<Date>2005</Date>
		<Volumn>33</Volumn>
		<Issue>4</Issue>
		<Pages>1290-1297</Pages>
	</Reference>
	<Revision>
		<rDate Reviser="antisenseml">2006-08-27</rDate>
	</Revision>
</AntisenseML>
